Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue?

被引：4
作者：
Dicembrini, Ilaria [1 ]
Mannucci, Edoardo [1 ]
机构：
[1] Careggi Teaching Hosp, Diabetol, Florence, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 184卷
关键词：
Type; 2; diabetes; Myocardial infarction; Dipeptidyl Peptidase 4 inhibitors; METAANALYSIS;
D O I：
10.1016/j.ijcard.2015.02.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [21] Dipeptidyl Peptidase-4 Inhibitors and Their Effects on the Cardiovascular System
    Solun, B.
    Marcoviciu, D.
    Dicker, D.
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (08)
  • [22] Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
    Apaijai, Nattayaporn
    Inthachai, Tharnwimol
    Lekawanvijit, Suree
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    JOURNAL OF ENDOCRINOLOGY, 2016, 229 (03) : 245 - 258
  • [23] Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection
    Marina Rankovic
    Nevena Jeremic
    Ivan Srejovic
    Katarina Radonjic
    Aleksandra Stojanovic
    Milos Glisic
    Stefani Bolevich
    Sergey Bolevich
    Vladimir Jakovljevic
    Heart Failure Reviews, 2021, 26 : 437 - 450
  • [24] The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors
    Avogaro, Angelo
    Fadini, Gian Paolo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (08) : 1686 - 1695
  • [25] Effect of Dipeptidyl Peptidase-4 Inhibitors on the Risk of Bone Fractures in a Korean Population
    Ustulin, Morena
    Park, So Young
    Choi, Hangseok
    Chon, Suk
    Woo, Jeong-Taek
    Rhee, Sang Youl
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (35)
  • [26] Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
    Kim, Seoyoung C.
    Glynn, Robert J.
    Liu, Jun
    Everett, Brendan M.
    Goldfine, Allison B.
    ACTA DIABETOLOGICA, 2014, 51 (06) : 1015 - 1023
  • [27] Systematic review and meta-analysis: dipeptidyl peptidase-4 inhibitors and rheumatoid arthritis risk
    Wang, Miao
    Li, Muqin
    Xie, Ying
    ENDOCRINE JOURNAL, 2021, 68 (06) : 729 - 738
  • [28] Dipeptidyl peptidase-4 inhibitors in type 2 diabetic elderly patient
    Doucet, Jean
    Bauduceau, Bernard
    Blickle, Jean-Frederic
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2011, 9 (02): : 157 - 162
  • [29] Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials
    Yang, Na
    He, Li-Yun
    Liu, Peng
    Li, Zi-Yi
    Yang, Yu-Cheng
    Ping, Fan
    Xu, Ling-Ling
    Li, Wei
    Zhang, Hua-Bing
    Li, Yu-Xiu
    WORLD JOURNAL OF DIABETES, 2024, 15 (05)
  • [30] Overview of the Gliptin Class (Dipeptidyl Peptidase-4 Inhibitors) in Clinical Practice
    Bohannon, Nancy
    POSTGRADUATE MEDICINE, 2009, 121 (01) : 40 - 45
12345